- Home
- Industry Reports
- Information Communications Technology
- infrastructure
- Microfluidics Market – Size, Outlook, Trends and Forecast (2024 – 2032)
Microfluidic is a term which manipulates and controls the fluids which are at a range of microliters to picoliters in a network channel. Microfluidics is used in various fields such as chemistry, physics, engineering, nanotechnology and biotechnology where low volume fluids are to be controlled to achieve multiplexing, automation and some others.
Microfluidics Market Segments Size & Growth:
Microfluidics Market is accounted for $XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth by demand for point of care testing and approval for personalised medicine. Though, complex regulatory approval process hampers the growth of the Microfluidics market.
Microfluidics Market Segments Share:
Microfluidics market is categorised into by material which consists polymer-based, glass-based, silicon-based, and some others. Polymer-based microfluidics is expected to grow at a quick pace due to high reliability and increasing application in various diagnostic fields. By components, it is classified by microchips, micropumps, microfluidics cartridges and reagents, Micronozzles, Microvalves, and so on. Microfluidics cartridges & reagents are the leading markets owing to the high usage of cartridges and reagents in laboratories. In-Vitro diagnostics is projected to have the highest growth among other application due to the rising demand for point of care testing in the healthcare sector. By end-user, it is segmented as pharmaceutical, academic & research, diagnostic lab, drug delivery services and some others. Pharmaceutical is projected to have a significant growth because of the demand for point of care and helps to monitor cancer as well as cardiovascular disorders. By Geography, North America is dominating the growth of the Microfluidics market and the growth in North America is mainly attributed because of huge insurance schemes for lab testing and medical reimbursements. Furthermore, Asia-Pacific is witnessing the fastest growth during the forecast period, due to increase in R&D and rise in healthcare expenditure.
Microfluidics Market Segments Trends:
- In September 2017, PerkinElmer, Inc. has launched new MD system QSight 210 for clinical laboratories to provide better results.
- In March 2016, Agilent technologies launched a novel platform for analysing cell-free DNA to help researchers to have a clear picture.
Microfluidics Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Roche Diagnostics Limited
- PerkinElmer, Inc.
- Agilent Technologies
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Demand for Point of Care testing
4.1.2 Fast return on investments
4.1.3 Approval for personalized medicine
4.2 Restraints
4.2.1 Complex regulatory approval process
4.2.2 Rise alternative technologies
4.3 Opportunities
4.3.1 Demand in Asian market
4.3.2 Emerging drug delivery technologies
4.4 Challenges
4.4.1. Lack of awareness of microfluidics products
4.4.2 High-cost sensors.
Chapter 5 Microfluidics Market – By Material
5.1 Polymer-based Microfluidics
5.2 Glass-based Microfluidics
5.3 Silicon-based Microfluidics
5.4 Others
Chapter 6 Microfluidics Market – By Components
6.1 Microchips
6.2 Micropumps
6.3 Micronozzles
6.4 Microvalves
6.5 Microfluidics cartridges and reagents
6.6 Others
Chapter 7 Microfluidics Market – By Application
7.1 Microdispensing
7.2 Drug Delivery
7.3 High-Throughput Screening
7.3.1 Genome Analysis
7.3.2 Lab Automation
7.3.3 Assays
7.4 Life science research
7.4.1 Proteomics
7.4.1.1 Immunoassay
7.4.1.2 High-Pressure Liquid Chromatography
7.5 In-Vitro Diagnostics
7.6 Others
Chapter 8 Microfluidics Market – By End User
8.1 Pharmaceutical
8.2 Academic & Research
8.3 Diagnostic Lab
8.4 Drug delivery services
8.5 Others
Chapter 9 Microfluidics Market – By Geography
9.1 Introduction
9.2 North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3 Europe
9.3.1. U.K.
9.3.2. Germany
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4 Asia Pacific
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. South Korea
9.4.5. Australia & New Zealand
9.4.6. Rest of APAC
9.5 South America
9.5.1. Brazil
9.5.2. Argentina
9.5.3. Others
9.6. Middle East & Africa
9.6.1. Middle East
9.6.2. Africa
Chapter 10 Microfluidics Market – Company Profiles
10.1. Roche Diagnostics Limited
10.2. PerkinElmer, Inc.
10.3. Agilent Technologies
10.4. Bio-Rad Laboratories, Inc.
10.5. Danaher Corporation
10.6. Hoffmann-La Roche Ltd.
10.7. Illumina, Inc.
10.8. Becton, Dickinson, And Company
10.9. Cepheid
10.10. Caliper Life Sciences, Inc.
10.11. Hewlett-Packard
10.12. Microfluidic Systems Inc.
10.13. RainDance Technologies
10.14. Micronit Microfluidics Bv
10.15. Intelligent Micro Patterning Llc
Chapter 11 Microfluidics Market – Competitive Landscape
11.1. Market Share Analysis
11.2. Strategies Adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 12 Market Insights
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,489.86 - €7,469.57
- INR: ₹225,053.86 - ₹675,161.59
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,133.43 - £6,400.30
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Microfluidic is a term which manipulates and controls the fluids which are at a range of microliters to picoliters in a network channel. Microfluidics is used in various fields such as chemistry, physics, engineering, nanotechnology and biotechnology where low volume fluids are to be controlled to achieve multiplexing, automation and some others.
Microfluidics Market Segments Size & Growth:
Microfluidics Market is accounted for $XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth by demand for point of care testing and approval for personalised medicine. Though, complex regulatory approval process hampers the growth of the Microfluidics market.
Microfluidics Market Segments Share:
Microfluidics market is categorised into by material which consists polymer-based, glass-based, silicon-based, and some others. Polymer-based microfluidics is expected to grow at a quick pace due to high reliability and increasing application in various diagnostic fields. By components, it is classified by microchips, micropumps, microfluidics cartridges and reagents, Micronozzles, Microvalves, and so on. Microfluidics cartridges & reagents are the leading markets owing to the high usage of cartridges and reagents in laboratories. In-Vitro diagnostics is projected to have the highest growth among other application due to the rising demand for point of care testing in the healthcare sector. By end-user, it is segmented as pharmaceutical, academic & research, diagnostic lab, drug delivery services and some others. Pharmaceutical is projected to have a significant growth because of the demand for point of care and helps to monitor cancer as well as cardiovascular disorders. By Geography, North America is dominating the growth of the Microfluidics market and the growth in North America is mainly attributed because of huge insurance schemes for lab testing and medical reimbursements. Furthermore, Asia-Pacific is witnessing the fastest growth during the forecast period, due to increase in R&D and rise in healthcare expenditure.
Microfluidics Market Segments Trends:
- In September 2017, PerkinElmer, Inc. has launched new MD system QSight 210 for clinical laboratories to provide better results.
- In March 2016, Agilent technologies launched a novel platform for analysing cell-free DNA to help researchers to have a clear picture.
Microfluidics Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Roche Diagnostics Limited
- PerkinElmer, Inc.
- Agilent Technologies
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Demand for Point of Care testing
4.1.2 Fast return on investments
4.1.3 Approval for personalized medicine
4.2 Restraints
4.2.1 Complex regulatory approval process
4.2.2 Rise alternative technologies
4.3 Opportunities
4.3.1 Demand in Asian market
4.3.2 Emerging drug delivery technologies
4.4 Challenges
4.4.1. Lack of awareness of microfluidics products
4.4.2 High-cost sensors.
Chapter 5 Microfluidics Market – By Material
5.1 Polymer-based Microfluidics
5.2 Glass-based Microfluidics
5.3 Silicon-based Microfluidics
5.4 Others
Chapter 6 Microfluidics Market – By Components
6.1 Microchips
6.2 Micropumps
6.3 Micronozzles
6.4 Microvalves
6.5 Microfluidics cartridges and reagents
6.6 Others
Chapter 7 Microfluidics Market – By Application
7.1 Microdispensing
7.2 Drug Delivery
7.3 High-Throughput Screening
7.3.1 Genome Analysis
7.3.2 Lab Automation
7.3.3 Assays
7.4 Life science research
7.4.1 Proteomics
7.4.1.1 Immunoassay
7.4.1.2 High-Pressure Liquid Chromatography
7.5 In-Vitro Diagnostics
7.6 Others
Chapter 8 Microfluidics Market – By End User
8.1 Pharmaceutical
8.2 Academic & Research
8.3 Diagnostic Lab
8.4 Drug delivery services
8.5 Others
Chapter 9 Microfluidics Market – By Geography
9.1 Introduction
9.2 North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3 Europe
9.3.1. U.K.
9.3.2. Germany
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4 Asia Pacific
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. South Korea
9.4.5. Australia & New Zealand
9.4.6. Rest of APAC
9.5 South America
9.5.1. Brazil
9.5.2. Argentina
9.5.3. Others
9.6. Middle East & Africa
9.6.1. Middle East
9.6.2. Africa
Chapter 10 Microfluidics Market – Company Profiles
10.1. Roche Diagnostics Limited
10.2. PerkinElmer, Inc.
10.3. Agilent Technologies
10.4. Bio-Rad Laboratories, Inc.
10.5. Danaher Corporation
10.6. Hoffmann-La Roche Ltd.
10.7. Illumina, Inc.
10.8. Becton, Dickinson, And Company
10.9. Cepheid
10.10. Caliper Life Sciences, Inc.
10.11. Hewlett-Packard
10.12. Microfluidic Systems Inc.
10.13. RainDance Technologies
10.14. Micronit Microfluidics Bv
10.15. Intelligent Micro Patterning Llc
Chapter 11 Microfluidics Market – Competitive Landscape
11.1. Market Share Analysis
11.2. Strategies Adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 12 Market Insights
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.